Abstract Number: 209 • ACR/ARP Annual Meeting 2019
Daisuke Kobayashi1, Sachimi Amao 2, Satoshi Ito 3, Kiyoshi Nakazono 3, Hajime Ishikawa 4 and Ichiei Narita 1, 1Division of Clinical Nephrology and Rheumatology, Niigata University, Niigata, Niigata, Japan, 2Nursing department, Niigata Rheumatic Center, Shibata, Japan, 3Department of Rheumatology, Niigata Rheumatic Center, Shibata, Japan, 4Department of Rheumatology, Niigata Rheumatic Center, Shibata, Niigata, Japan
Background/Purpose: The development of drug therapies for rheumatoid arthritis (RA), and control of synovitis has now become easier. However, once patients are relieved of pain,…